Literature DB >> 16325672

DiGeorge syndrome: new insights.

Elizabeth Goldmuntz1.   

Abstract

Most patients with the clinical features of DiGeorge, velocardiofacial, and conotruncal anomaly face syndromes share a common genetic cause, namely, a deletion of chromosome 22q11, and define the most common deletion syndrome known at this time. The clinical features of the 22q11 deletion syndrome are highly variable between individuals; some have subtle findings, whereas others are severely affected. The most common clinical features include specific types of congenital heart disease, hypocalcemia, immunodeficiency, facial dysmorphia, palate anomalies, velopharyngeal dysfunction, renal anomalies, and speech and feeding disorders as well as neurocognitive, behavioral, and psychiatric disorders. A significant number of patients with tetralogy of Fallot, truncus arteriosus, an interrupted aortic arch, isolated aortic arch anomalies, and perimembranous ventricular septal defects have a 22q11 deletion. Routine testing for a 22q11 deletion in this subset of patients should be considered to provide anticipatory medical intervention and appropriate family counseling.

Entities:  

Mesh:

Year:  2005        PMID: 16325672     DOI: 10.1016/j.clp.2005.09.006

Source DB:  PubMed          Journal:  Clin Perinatol        ISSN: 0095-5108            Impact factor:   3.430


  15 in total

Review 1.  A review of neurocognitive and behavioral profiles associated with 22q11 deletion syndrome: implications for clinical evaluation and treatment.

Authors:  Opal Ousley; Kimberly Rockers; Mary Lynn Dell; Karlene Coleman; Joseph F Cubells
Journal:  Curr Psychiatry Rep       Date:  2007-04       Impact factor: 5.285

2.  Deletion 22q11.2: report of a complex meiotic mechanism of origin.

Authors:  Sintia Iole Nogueira; April M Hacker; Fernanda T S Bellucco; Leslie Domenici Kulikowski; Denise Maria Christofolini; Mirlene C Cernach; Maria Isabel Melaragno; Beverly S Emanuel
Journal:  Am J Med Genet A       Date:  2007-08-01       Impact factor: 2.802

3.  Severe dystrophy in DiGeorge syndrome.

Authors:  Barnabás Rózsai; Akos Kiss; Györgyi Csábi; Márta Czakó; Tamás Decsi
Journal:  World J Gastroenterol       Date:  2009-03-21       Impact factor: 5.742

4.  PRODH rs450046 and proline x COMT Val¹⁵⁸ Met interaction effects on intelligence and startle in adults with 22q11 deletion syndrome.

Authors:  Mariken B de Koning; Esther D A van Duin; Erik Boot; Oswald J N Bloemen; Jaap A Bakker; Kathryn M Abel; Thérèse A M J van Amelsvoort
Journal:  Psychopharmacology (Berl)       Date:  2015-06-12       Impact factor: 4.530

5.  Aortic root dilation in patients with 22q11.2 deletion syndrome.

Authors:  Anitha S John; Donna M McDonald-McGinn; Elaine H Zackai; Elizabeth Goldmuntz
Journal:  Am J Med Genet A       Date:  2009-05       Impact factor: 2.802

6.  Evaluation of potential modifiers of the cardiac phenotype in the 22q11.2 deletion syndrome.

Authors:  Elizabeth Goldmuntz; Deborah A Driscoll; Beverly S Emanuel; Donna McDonald-McGinn; Minghua Mei; Elaine Zackai; Laura E Mitchell
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2009-02

7.  Characterization of cultured thymus tissue used for transplantation with emphasis on promiscuous expression of thyroid tissue-specific genes.

Authors:  Bin Li; Jie Li; Chia-San Hsieh; Laura P Hale; Yi-Ju Li; Blythe H Devlin; M Louise Markert
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

Review 8.  Genetics of congenital heart disease: the glass half empty.

Authors:  Akl C Fahed; Bruce D Gelb; J G Seidman; Christine E Seidman
Journal:  Circ Res       Date:  2013-02-15       Impact factor: 17.367

9.  Congenital Heart Disease as a Warning Sign for the Diagnosis of the 22q11.2 Deletion.

Authors:  Marcília S Grassi; Cristina M A Jacob; Leslie D Kulikowski; Antonio C Pastorino; Roberta L Dutra; Nana Miura; Marcelo B Jatene; Stephanie P Pegler; Chong A Kim; Magda Carneiro-Sampaio
Journal:  Arq Bras Cardiol       Date:  2014-10-10       Impact factor: 2.000

10.  A pilot study on collective effects of 22q13.31 deletions on gray matter concentration in schizophrenia.

Authors:  Jingyu Liu; Alvaro Ulloa; Nora Perrone-Bizzozero; Ronald Yeo; Jiayu Chen; Vince D Calhoun
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.